Activin and Inhibin

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV),

IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent I K1 (K IR 2.x ion-channel-carried inward rectifier current) inhibitor, with IC 50 values of 12-15 nM for human and mouse K IR 2.x currents. IK1 inhibitor PA-6 (PA-6)

IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent I K1 (K IR 2.x ion-channel-carried inward rectifier current) inhibitor, with IC 50 values of 12-15 nM for human and mouse K IR 2.x currents. IK1 inhibitor PA-6 (PA-6)

IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent I K1 (K IR 2.x ion-channel-carried inward rectifier current) inhibitor, with IC 50 values of 12-15 nM for human and mouse K IR 2.x currents. IK1 inhibitor PA-6 (PA-6)

IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent I K1 (K IR 2.x ion-channel-carried inward rectifier current) inhibitor, with IC 50 values of 12-15 nM for human and mouse K IR 2.x currents. IK1 inhibitor PA-6 (PA-6)

IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent I K1 (K IR 2.x ion-channel-carried inward rectifier current) inhibitor, with IC 50 values of 12-15 nM for human and mouse K IR 2.x currents. IK1 inhibitor PA-6 (PA-6)

IKK-IN-1 is an inhibitor of IKK extracted from patent WO2002024679A1, compound example 18-13.Form:SolidIC50&amp: Target:IKK.

IKK-IN-1 is an inhibitor of IKK extracted from patent WO2002024679A1, compound example 18-13.Form:SolidIC50&amp: Target:IKK.

IKK-IN-1 is an inhibitor of IKK extracted from patent WO2002024679A1, compound example 18-13.Form:SolidIC50&amp: Target:IKK.

IKK-IN-1 is an inhibitor of IKK extracted from patent WO2002024679A1, compound example 18-13.IC50&amp: Target:IKK.

IKKγ NBD Inhibitory Peptide TFA is a highly specific inhibitor NF-κB inhibitor. IKKγ NBD Inhibitory Peptide TFA acts by disrupting the interaction between IKKγ/NEMO-binding domain (NBD) with IKKα and IKKβ, thus blocking TNF-α-induced NF-kB

IKKγ NBD Inhibitory Peptide TFA is a highly specific inhibitor NF-κB inhibitor. IKKγ NBD Inhibitory Peptide TFA acts by disrupting the interaction between IKKγ/NEMO-binding domain (NBD) with IKKα and IKKβ, thus blocking TNF-α-induced NF-kB